Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like you got your shares at a great price. I'm a little surprised your accumulation didn't move the PPS up a few pennies.
Feeling positive after a good weekend.
Saturday marked the 15th annual Crest Invitational Poker Tournament. After 12 hours of play, I walked away with my second championship.
On Sunday, the Chargers (6-4) beat the Raiders (0-10). Leaving San Diego firmly in the playoff hunt and Oakland just six games away from a perfect season.
Feeling positive after a good weekend.
Saturday marked the 15th annual Crest Invitational Poker Tournament. After 12 hours of play, I walked away with my second championship.
On Sunday, the Chargers (6-4) beat the Raiders (0-10). Leaving San Diego firmly in the playoff hunt and Oakland just six games away from a perfect season.
Thank you! I think there is a good chance we are now in a two week window when financials could be released. If not in the next two weeks, then we are likely going to suffer another Qtr.
Are you trying to scare the powers that be to report after the markets close today?
It is more about perception of accurate reporting and future profitability than the numbers for many stocks. Here is the proof.
I'm watching two stocks that reported this morning CANV and SIAF.
CANV revenue was down 38% from the $3M reported in 2Q/14, and Net Ordinary Income swung to a $490K operating loss. CANV is currently trading positive up .07 to $3.19
SIAF reported record Quarterly Revenue of $107.2M and Diluted EPS of $.14. SIAF is down .0101 to .90 a share.
Good points! Hopefully tomorrow's financials will come with some news. The news, like a new major distributor, may be more important than the numbers.
Someone give up and dump 151,000 shares?
That was a great article.
I was imagining a pump without any real new news. However, you bring up a great point that I hadn't really even considered. When the financials are released, we will likely get pumped hard. This will make for some difficult decisions. Is the price per share reflective of the financials, or the pump. If it's the pump, then the wise move would be to get out right away. But I think many of us would want to stay around for the long run to see how high it can go.
Poll: What would you do if FCPG got pumped again?
I'm curious what would you all do if FCPG got pumped again prior to financials coming out?
The stock usually jumps on a pump and then quickly falls down and often to a level below than it was before the pump.
Would this create an opportunity to cash out some shares and possibly re-invest when it drops?
Or, would you be too afraid that the financials may come out during the pump and would just ride it up and down?
Honestly, I think/hope I would take advantage of the opportunity.
Dan's Never Right Prediction: The ask is $3.30. We will probably gap to open at that and then bounce around the two resistant points. At the end of the day we will break through and close at around $3.45.
I don't mind it. The daily price before the financials comes out means nothing. I have a couple other stocks performing well. Before FCPG financials come out, I hope one of them breaks out to give me the cash to add to my position at shorter's expense.
What is your goal for Wednesday after CANV past your Tuesday goal of $3.09?
That would be awesome!
Looks like $3.00 is offering some serious resistance today. We will get there, but must get past $3.00 before any run.
Thanks all! I'm now 7-3, fist place in my division and tied for best overall record in our 12 team league. However, several times I have benefited from playing the right opponent on their down week. It is going to be battle to the end.
I have written for various outlets over the last 7 years. From 2010-12 seasons I worked full-time for CBSSports as the Chargers beat writer. Unfortunately they let everyone go. The release from work coincided with a growing familiarly, so my household is a bit of a role reversal as a stay at home dad. I'm still dreaming of a big FCPG payday.
I will be contributing to an article on the search for a new Chargers stadium which should be published this week If you like, I will put up a link here.
For those that are not chart experts, can you do a little explaining on what you are seeing and what you entered to create the chart?
Cutler likely will never succeed to his level of talent because his personality prohibits him from being a true leader. Oh, the stories I heard about Cutler from from former Broncos team writer Chris Smith when he was the team Chargers team writer.
Unfortunately, WR Brandon Marshall still had a good night. Yesterday, posted by far my best week in fantasy football this season. My opponent also had his best and has Marshall. He took the lead on Marshall ' s final catch. Now I need 6 points from the Eagles kicker tonight to win.
It will be 2-years on the 19th since FCPG posted financials So, this week is possible.
CANV is a highly volatile stock. This creates opportunities for both the longs and the shorts. Pick a side and wait for it to go in your direction. However, it appears it is best to go long. If you go short you have the potential for unlimited exposure.
I have no idea if NES is going up or down in the near future. There are no experts, only educated guessers.
In general, I was pleased with the results today. They signaled to me the beginning of a turnaround.
There are still a lot of issues in terms of debt. This makes me concerned about cash flow flexibility and the ability to grow.
I was encouraged that we finally saw a quarter with a significant increase in revenue, and a stronger forecast for the immediate future. It was also nice to hear some big financial firms asking poignant questions on the conference call, instead of concerned individual stock holders.
Big money is what makes stock prices move. It will only takes one of them to start moving into NES to send the price up quickly. The recipe for a quick rise in stock price is there with a low float and high short interest that will need to cover.
With that said, I would not be shocked to see it go down to $5 in the near future. For the first time in the longtime, however, I think things are pointed in the right direction.
I just finished listening to the conference call. I think NES has began to turn the corner. More positive than negative.
I think we have the beginning of the turnaround. I suspect some shorters will cover tomorrow. Let's see where we are at three months from now.
Should our expectations be muted on what happens after financials released?
Many of us are expecting FCPG to head north into the multi-dollar range when/if financials are released. I wonder if that is overly optimistic.
SIAF is Chinese company that is current on their financials. They are growing fast, reported nearly 100 million (97 million) in revenue last quarter, and had an earnings of .14 per share. Yet SIAF stock sits at .9301 at close of today.
http://ih.advfn.com/p.php?pid=nmona&article=63274075
Could FCPG face a similar fate? What are your thoughts?
Should our expectations be muted on what happens after financials released?
Many of us are expecting FCPG to head north into the multi-dollar range when/if financials are released. I wonder if that is overly optimistic.
SIAF is Chinese company that is current on their financials. They are growing fast, reported nearly 100 million (97 million) in revenue last quarter, and had an earnings of .14 per share. Yet SIAF stock sits at .9301 at close of today.
http://ih.advfn.com/p.php?pid=nmona&article=63274075
Could FCPG face a similar fate? What are your thoughts?
Good analysis!
Lesson of the Day: Nobody Knows Anything
Most of us thought CANV would jump today and it dropped significantly. Unfortunately, this is typical. There are no experts, only educated guesses.
This doesn't mean it won't jump soon. Maybe next week with earnings, or an announcement of a new distributor.
If it does pop it will likely happen at an unexpected time. If you believe in the company, you wait it out. If you were only looking for a quick buck, then suck up your losses and move on. This type of investing, however, usually leads to losses.
I read SIAF last quarter results. Truly impressive that it had .14 earnings per share and the share price is less than a dollar. However, maybe that is .02 earnings when doing the conversion from Yuan. Do you know if their numbers are audited by well recognized firm.
Love to learn more on what you are doing. I'm surprised with the CANV drop, but I think shorters created a little scare and will quickly rebound.
Anyone have reason to believe that we will be pleasantly surprised with some good news tomorrow instead of a bunch of excuses with more promises for the future?
Anyone seeing any results yet?
Hey FCPG board, you know that I do not use this forum a lot to pump other stocks. I am taking the liberty to do so today because CANV is time sensitive. If I am correct on this pick, I plan to invest the profits back into FCPG.
CANV is leader in the medical marijuana industry and recent winner of the Cannabis CUP. After Washington and Colorado legalized marijuana, CANV went from about $4.50 a share all the way up to $201. This was the second extreme spike in consecutive years.
CANV came back down to the $2 range where I got in. In large part, this is because the shares became somewhat diluted as insider shares matured. However, they are still low float and priced under their competitors.
Today, four states are voting on legalization. All four propositions will likely pass. If this happens, once again there will be a ton of media attention focused on the marijuana industry and could easily set up the third pot stock boom. Because CANV is a leader with quality product, they could again see a significant pop in their price.
I put in about $1,000. Now at $3.50, my hopes is that it will at least reach the $15.00 mark. This would allow me take the profits and pick up 100,000 shares of FCPG.
Hey FCPG board, you know that I do not use this forum a lot to pump other stocks. I am taking the liberty to do so today because CANV is time sensitive. If I am correct on this pick, I plan to invest the profits back into FCPG.
CANV is leader in the medical marijuana industry and recent winner of the Cannabis CUP. After Washington and Colorado legalized marijuana, CANV went from about $4.50 a share all the way up to $201. This was the second extreme spike in consecutive years.
CANV came back down to the $2 range where I got in. In large part, this is because the shares became somewhat diluted as insider shares matured. However, they are still low float and priced under their competitors.
Today, four states are voting on legalization. All four propositions will likely pass. If this happens, once again there will be a ton of media attention focused on the marijuana industry and could easily set up the third pot stock boom. Because CANV is a leader with quality product, they could again see a significant pop in their price.
I put in about $1,000. Now at $3.50, my hopes is that it will at least reach the $15.00 mark. This would allow me take the profits and pick up 100,000 shares of FCPG.
Thanks John, I put SIAF and TTWO on my watch list. I really appreciate having a second person on this board. Do you follow Rule One Investing techniques? It sounds like you may and that SIAF and TTWO are perfect RULE ONE stocks.
There are two stocks that I am excited because of circumstances that you may want to take a look at: CANV and FCPG. These are NOT Rule One stocks, but worth a look.
CANV: This is a leader in marijuana industry and winner of the Canvas Cup. It is low float, Last year the stock jumped to $201 and fell down to mid $2 range where I got in. It currently is at $3.41. There are four states that are voting on legalization today and all four of those props are expected to pass. If they do, pot stocks could become hot again. CANV likely will not hit $201 again because there is more shares in circulation now, but still a tremendous room to grow. The stock is already moving upward today in expectation of election results.
FCPG: The best way to learn about is one of six companies that has a certificate to sell pharmaceuticals in on-line in China. They recently completed construction of a state-of-the-art distribution facility and are hiring. However, most of this information can only be found by doing research. There have not reported for two years because there are discrepancies between the US and China when it comes to auditing. Without reporting the stock has plunged into low penny land. FCPG hired Marcum, a major US auditor last October. It is expected up to date financials will be released soon. We are expecting revenues of around $100 million and a 20 percent growth rate. Anywhere near that and FCPG will quickly be out of penny land. Maybe worth picking up 10,000 shares for fun. Read the FCPF board for more info. It is a fun group.
I reviewed over 1,200 stocks and this was the most undervalued. I'm very excited about the fundementals. It may just take time for others to discover this stock. I'm glad you did.
All props will likely pass according to polls I read last week.
Our Modern Pharmaceutical Logistics Plant is Completed!
This article indicates the new plant is on-line and FCPG is a leader.
Third-party logistics modern medicine research (Yunnan) summit successfully finished
http://www.sinohealth.com/2014/0825/8540.shtml
Changzhou Logistics Company: July 26, sponsored by the pharmaceutical Observer newspaper and Pharmaceutical Industry Association of Yunnan Province, Kunming Pharmaceutical Co., Ltd. Xinyuan Church hosted the third modern Pharmaceutical Logistics Seminar (Yunnan) summit held in Kunming, Yunnan cloud???. Deputy director of Yunnan Provincial Food and Drug Administration Xing Yawei, president of the Pharmaceutical Industry Association of Yunnan Province???to be congratulated, and the rise of modern logistics enterprises in Yunnan pinned high hopes.
As a good representative of Yunnan local modern pharmaceutical logistics companies - Kunming Pharmaceutical Co., Ltd., general manager of Tong Xinyuan Crystal Palace forum topics report on the status quo of modern pharmaceutical logistics Yunnan third parties profound analysis, while the vision of the Church Xinyuan and practice analysis and sharing. She believes that, at present, many, Yunnan pharmaceutical distribution organization has qualified pharmaceutical wholesale enterprises seem unreasonable, although the number, but it is mixed, dispersed competition is to enable enterprises to small-scale, difficult to achieve economies of scale and economies of scope.
The modern pharmaceutical logistics center Xinyuan Church Phase II project by Hong Kong's first Chinese pharmaceutical, Kunming Pharmaceutical Investment Xinyuan Church has been completed, relying on modern logistics facilities will effectively reduce logistics costs and improve logistics operational efficiency, improve circulation and business-related services processing, procurement and other aspects of the transaction. To better meet the medical products manufacturer based in Yunnan, for Southeast Asia to reduce transaction costs, enhance product competitiveness needs.
After the keynote speech at the summit, organized a committee leaders, experts, and entrepreneurs to Xinyuan modern logistics center court conducted a site visit, representatives of the pharmaceutical logistics Xinyuan Church on the application of Internet technology gave a high evaluation, the success of its e-commerce platform expressed a strong interest.
According to the reporter, the summit far-reaching, attracted nearly 200 delegates from Shandong Sunrise, Shandong Global, four coron, Ring Section Po, Kunming Pharmaceutical Group, more than 80 companies attended the meeting of delegates of the Forum Keynote were fully interactive, analyzed and discussed, and its theoretical exploration and practice cases will promote the healthy development of the share of modern pharmaceutical logistics.
Over 20% margin for Chinese online drug transaction, traditional 3-5%
This article doesn't mention FCPG, but talks about on-line profit margin.
The advent of the Internet era drug pharmaceutical companies "net"
http://www.sinohealth.com/2014/0811/7600.shtml
Recently, Chinese listed companies publish Yiling Pharmaceutical midday announcement, the company, a wholly owned sub-subsidiary Shijiazhuang Yiling Medic large pharmacy chain Limited has been in Hebei Province Food and Drug Administration issued a Certificate of Internet and drug transaction services.
Yiling Pharmaceutical companies have expressed to zhengbao obtain the certificate, will achieve drugs online under a single transaction, the type of service in favor of rich companies to improve the company's brand and reputation of the market. This positive push the stock the same day (August 4) rose 4.32% intraday.
It's just listed pharmaceutical company "net" tide in a microcosm. This year, Kyushu, Hong Mei medicine and other listed companies have begun to enter the online sale of drugs, posture chain extends clear to the Internet.
As Health America Pharmaceutical announcement in early April, a wholly owned subsidiary company of Guangdong, Hong Mei Zhi Lian large pharmacy chain Limited obtained the "Internet and drug transaction services qualification certificate." It is learned that love big pharmacy Combibloc's online store will provide medicines to individual consumers.
Hong Mei medicine has significantly accelerated the electricity supplier business development. First proposed in the 2013 annual report, e-commerce will become the core of the company's future development strategy, and made by the whole industry chain development model of traditional Chinese medicine advocates to change provider role.
In addition, Hill Asia-Pharmaceutical chairman Renwu Xian has made it clear to reporters that the company will enter the Internet at the end of the year, beginning in online sales of health care products, nutritional supplements, etc., before the end of the year he sold the business to the Internet company's goal is to develop development of 30 million yuan, and related health care products, etc. have been completed, the production line construction is completed.
Of more concern is that the pharmaceutical distribution industry with the Internet giant join forces to create online pharmacies ambitions. It is reported that, Kyushu has launched a series of Tencent micro-channel in-depth cooperation, has been developed to achieve a micro-channel to the line pharmacies O2O business "drug delivery" business functions to achieve the user to quickly send in a short time through the micro-channel orders, drug through pharmacies up mode, to become the first to carry out micro-channel medicine class O2O business users. Currently, pharmacists have provided good service to the next shop down the line two-dimensional code scanning micro-channel single pay line in Beijing and Shanghai, more than 200 pharmacies, and drug delivery services online to offline. Said the pilot, once mature, will be to other cities across the country. The company's goal is to build six hours drug delivery door O2O "drug delivery" service platform.
In January this year, Alibaba stake in CITIC 21CN, which the Department of CITIC Group medical information and transaction services platform, but also has a domestic drug sales on a third-party online certificate pilot license. Many industry insiders believe the move will make online pharmacies Alibaba objective to become one of the newest attraction this year in the pharmaceutical industry.
It should be noted that, despite the current chaos online drug transaction, and the transaction size is not large. However, according to Kyushu disclosed that the company online drug transaction margin over 20%, while gross profit drug trade for many years under the general line is maintained at between 3% -5%. In the case of logistics increasingly developed, online drug trade will undoubtedly be more attractive. In fact, third-party online drug sales Administration of the State Food and Drug Administration is being piloted, not just for pharmaceutical distribution companies, pharmaceutical industrial enterprises are also expected to sell drugs directly to the Internet.
Chinese Pharmaceutical Sector Investment Hot: Kunming Pharmaceutical mentioned in July Merger and Acquisitions Article.
Again, I am not sure if this is the correct Kunming Pharmaceutical, but speaks to the industry as whole and their effort to become state of the art.
Pharmaceutical sector investment hot
http://www.sinohealth.com/2014/0721/5905.shtml
Recently, the Aibo Wei acquired Charles case confusing, up $ 53.7 billion offer pocketed industry people's attention. This year, the multinational pharmaceutical companies merger populations everywhere, Pfizer and AstraZeneca's story is not over, mergers and acquisitions of domestic pharmaceutical industry has followed.
According to Wind statistics, in the first half of this year, pharmaceutical companies merger cases amounted to 27.525 billion yuan, even more than the 2013 annual 23.087 billion yuan of scale. If you include foreign mergers and acquisitions of non-listed companies, mergers and acquisitions amount realm of health will rise.
Earlier this year, Bayer's acquisition price of 3.6 billion yuan Dianhong medicine, industry boos. Not only transaction amount more, the survival status of domestic enterprises as well as strong foreign invasion sigh.
In macro-economic situation is not optimistic about the situation, pharmaceutical companies rely on endogenous development becomes more difficult, and epitaxial acquisitions to become the choice of many enterprises moment. From the field of mergers and acquisitions, the pharmaceutical field position of absolute dominance. And this trend from last year has already begun.
Qing dynasties report shows that in 2013, more than 80 pharmaceutical companies involved in investment, while more than 50 medical devices, medical services 29. Although recent medical devices and medical services investment has been heating up, but in all areas of health care investment in the pharmaceutical sector is still the largest proportion of investment.
From the acquisition perspective, the pharmaceutical industry accounted for 46% of all mergers and acquisitions, followed by 33% of medical equipment, from the acquisition amount, the pharmaceutical accounted for 67%, 23% of medical equipment. In these, many of which are listed companies to make strategic investments and acquisitions.
Buyout funds compete for approval
According to industry observers, from the beginning of 2013, pharmaceutical companies to significantly accelerate the pace of mergers and acquisitions, including China Resources Sanjiu on Hailai Shi, Dunlop medical, biological Watson, John Hancock Medical, Xinhua medical mergers and acquisitions of listed companies are very active.
In order to accelerate faster to participate in mergers and acquisitions, there are still some companies set up pharmaceutical industry fund mergers and acquisitions, the pharmaceutical industry mergers and acquisitions of listed companies to participate in the Fund has become the industry benchmark, only the beginning to now, have included Kunming Pharmaceutical, Levin US Pharmaceutical, 8 The company set up a fund set up to participate in mergers and acquisitions.
It is understood that since the beginning of the new GMP certification date, a large number of companies because of funding problems or technical barriers can not be completed certification, according to data released by the pharmaceutical sector, by the end of 2013, there were 796 sterile pharmaceutical production enterprises of all or part of the workshop by The newly revised GMP certification, accounting for all sterile drug manufacturing enterprises 60.3%.
Pharmaceutical Cube statistics of pharmaceutical production line January 1, 2013 between -2014 May 30 expiration date and the corresponding enterprises, found in the statistics of 1700 production line, has been inadequate by new GMP certified production lines 500, up to 71% of non- aseptic production line shutdown.
Regulatory authorities require drug manufacturers by new GMP certification, greatly improving the industry technical threshold and transformation costs, many without power transformation of businesses to choose a sell. SFC pattern of the past two years unissued shares, it is the eager help of public financing of enterprises in the door.
On the other hand, in the new market environment, a growing number of listed companies against the risk of a single species found great support businesses. For example in the constant group of Xueshuantong performance accounted for more than 70% contribution than in medicine prices sound, sustainable business development is being questioned.
Pharmaceutical manufacturing mergers and acquisitions, or to put it plainly, the approval number. Currently registered CFDA more stringent approval management, many companies get more high-quality medicines symbol through mergers and acquisitions.